Critical issues in the use of edaravone for the treatment of amyotrophic lateral sclerosis
Neurological Sciences · 2025
DOI: 10.1007/s10072-025-08154-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurological Sciences, 2025. Verfasst von Hung Youl Seok. Beteiligte Einrichtung: Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu, …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Edaravone, Neuroprotective Agents, Free Radical Scavengers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Edaravone, along with riluzole, is a key treatment for amyotrophic lateral sclerosis (ALS), with evidence supporting its efficacy in slowing disease progression, particularly in patients with early-stage ALS. Despite its approval and increasing clinical use, several critical questions about its use remain unanswered: Can edaravone be effective as monotherapy? Is it beneficial for patients who fall outside the inclusion criteria of pivotal trials? What is the optimal duration of treatment as ALS progresses? In addition, does edaravone provide clinical benefit to patients with familial ALS? Answering these questions is essential to optimize the use of edaravone in clinical practice and to further our understanding of its role in the treatment of ALS. This review synthesizes the current evidence to address these questions and identifies areas that require further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea. shy2354@gmail.com.
Zitieren
APA
Seok, H. Y. (2025). Critical issues in the use of edaravone for the treatment of amyotrophic lateral sclerosis. Neurological Sciences. https://doi.org/10.1007/s10072-025-08154-2
Vancouver
Seok HY. Critical issues in the use of edaravone for the treatment of amyotrophic lateral sclerosis. Neurological Sciences. 2025. doi:10.1007/s10072-025-08154-2
BibTeX
@article{Seok2025,
author = {Seok, Hung Youl},
title = {Critical issues in the use of edaravone for the treatment of amyotrophic lateral sclerosis},
journal = {Neurological Sciences},
year = {2025},
doi = {10.1007/s10072-025-08154-2}
}
EUVIMED